Challenges in early phase clinical trials for childhood cancer during the COVID-19 pandemic: a report from the new agents group of the Spanish Society of Paediatric Haematology and Oncology (SEHOP)

Document types check

Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/54486

Title:	Challenges in early phase clinical trials for childhood cancer during the COVID-19 pandemic: a report from the new agents group of the Spanish Society of Paediatric Haematology and Oncology (SEHOP)
Authors:	Rubio-San-Simón, A Verdú-Amorós, J Hladun, R Juan-Ribelles, A Molero-Luis, Marta Guerra-García, P Pérez-Martínez, Antonio Castañeda, A Cañete, A de Rojas, T Moreno, Lina Bautista, F View more
Filiation:	Hospital Infantil Universitario Nino Jesus, 28009 Madrid, Espana
Keywords:	COVID-19 Clinical research Clinical trials Development policy Paediatric haematology and oncology View more
Mesh:	COVID-19 Child Humans Medical Oncology Medical Staff, Hospital Neoplasms Patient Care Patient Selection SARS-CoV-2 Spain Surveys and Questionnaires Clinical Trials as Topic View more
Issue Date:	Jan-2021
Publisher:	Springer Science and Business Media LLC
Citation:	Clin Transl Oncol.2021 Jan;(23)1:183-189
Abstract:	The COVID-19 pandemic has forced healthcare stakeholders towards challenging decisions. We analyse the impact of the pandemic on the conduct of phase I-II trials for paediatric cancer during the first month of state of alarm in Spain.
PMID:	32472454
URI:	https://hdl.handle.net/20.500.12530/54486
Rights:	info:eu-repo/semantics/openAccess
Appears in Collections:	Fundaciones e Institutos de Investigación > FIB H. Infantil U. Niño Jesús > Artículos

Files in This Item:

File	Description	Size	Format
Article_ChallengesInEarlyPhaseClinical.pdf	ChallengesInEarlyPhaseClinical	723.82 kB	Adobe PDF	View/Open